Urological cancer, Malmö
491 – 500 of 555
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer
- Contribution to journal › Article
-
Mark
Single-Dose Antibiotic Prophylaxis in Core Prostate Biopsy: Impact of Timing and Identification of Risk Factors.
- Contribution to journal › Article
-
Mark
Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study
- Contribution to journal › Article
-
Mark
Words of wisdom. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- Contribution to journal › Article
- 2005
-
Mark
Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival
- Contribution to journal › Article
-
Mark
Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue
- Contribution to journal › Article
-
Mark
Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue
- Contribution to journal › Article
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
- Contribution to journal › Article
-
Mark
Lipopolysaccharide-binding protein is produced in the epididymis and associated with spermatozoa and prostasomes.
- Contribution to journal › Article
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
- Contribution to journal › Article
